When "flawed" translates into "flood": the unproven association between cancer incidence and glargine insulin therapy.
de Miguel-Yanes
Jose M
JM
Harvard Medical School, General Medicine Division, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
Meigs
James B
JB
D006801:Humans; D015994:Incidence; D007328:Insulin / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D000069036:Insulin Glargine; D049528:Insulin, Long-Acting; D009369:Neoplasms / Q000139:chemically induced* / Q000453:epidemiology; D012307:Risk Factors
D007328:Insulin; D049528:Insulin, Long-Acting; D000069036:Insulin Glargine